Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Stephens & Co. Maintains Equal-Weight on RXO, Maintains $20 Price Target

Stephens & Co. Maintains Equal-Weight on RXO, Maintains $20 Price Target

Stephens & Co. analyst Jack Atkins maintains RXO (NYSE:RXO) with a Equal-Weight and maintains $20 price target.

byBenzinga Newsdesk

February 8, 2023

1 minute read

Stephens & Co. analyst Jack Atkins maintains RXO (NYSE:RXO) with a Equal-Weight and maintains $20 price target.

Why LL Flooring Shares Are Sliding Today

By Akanksha Bakshi

May 8, 10:01 AM

LL Flooring Holdings, Inc. (NYSE:LL) reported a first-quarter FY23 sales decline of 13.7% year-on-year to $240.69 million, missing the consensus of…

Investigating Comcast’s Standing In Media Industry Compared To Competitors

By Benzinga Insights

January 5, 12:00 PM

Amidst the fast-paced and highly competitive business environment of today, conducting comprehensive company analysis is essential for investors…

CMCSA

News

Why Calidi Biotherapeutics (CLDI) Shares Are Down Over 50%

By Henry Khederian

April 16, 11:48 AM

Calidi Biotherapeutics shares are trading lower by 54% during Tuesday's session. The company announced the pricing of a $6.1 million public offering.

CLDI

Legal
News

AMMO Acknowledges Receipt Of Urvan Lawsuit

By Happy Mohamed

May 4, 5:08 PM

AMMO, Inc. (NASDAQ:POWW, POWWP)))) ("AMMO" or the "Company"), the owner of GunBroker.com, the largest online marketplace serving the firearms and shooting sports industries, and a leading vertically

POWW

Stephens & Co. Maintains Equal-Weight on RXO, Maintains $20 Price Target

Related Posts

Why LL Flooring Shares Are Sliding Today

Investigating Comcast’s Standing In Media Industry Compared To Competitors

Why Calidi Biotherapeutics (CLDI) Shares Are Down Over 50%

AMMO Acknowledges Receipt Of Urvan Lawsuit